Evidence map›Paper›PMID 42477424›Full record

ArticleCommunications chemistry2026

Metal-free strategy for C-N cross-coupling of benzamide with sulfonamide enabled by a Smiles rearrangement.

Sukhendu Pramanick, Sudipta Baur, Ashif Iqubal, Joydev K Laha, Srimanta Manna

Abstract read
In one paragraph

Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sukhendu PramanickDepartment of Pharmaceutical Technology (Process Chemistry), National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Punjab, India.
Sudipta BaurDepartment of Pharmaceutical Technology (Process Chemistry), National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Punjab, India.
Ashif IqubalDepartment of Chemistry and Chemical Biology, Indian Institute of Technology (Indian School of Mines), Dhanbad, India.ORCID http://orcid.org/0009-0001-9708-7426
Joydev K LahaDepartment of Pharmaceutical Technology (Process Chemistry), National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Punjab, India.ORCID http://orcid.org/0000-0003-0481-5891
Srimanta MannaDepartment of Pharmaceutical Technology (Process Chemistry), National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Punjab, India. srimanta@niper.ac.in.ORCID http://orcid.org/0000-0002-3903-1256

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

N-Substituted anilines and their derivatives are versatile building blocks for synthesizing pharmaceutical molecules, natural products, and functional materials. Given the significant role of biarylamine motifs in modern chemistry, the development of a mild and easily handleable protocol is highly desirable in contemporary organic synthesis. In this context, we develop a transition-metal-free C-N cross-coupling of carboxamides and sulfonamides, resulting in the synthesis of valuable biarylamines and alkylarylamines. This discovery represents an intermolecularly challenging Smiles rearrangement and introduces a method for synthesizing N-substituted anilines through the activation of carboxamides derived from carboxylic acids, a previously unexplored approach. The protocol showcases a broad substrate scope with various functional groups and scalability, providing access to key building blocks in medicinal chemistry and drug discovery. Furthermore, the developed protocol was successfully applied to 20 late-stage modifications of drugs and natural products containing primary amides derived from the corresponding acids.

Identifiers

PMID42477424
PMCPMC13385392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.